A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma (ANNOUNCE 2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02659020

Recruitment Status : Active, not recruiting

First Posted : January 20, 2016

Last Update Posted : November 18, 2020

Sponsor:

Information provided by (Responsible Party):

Eli Lilly and Company

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Actual Primary Completion Date :	July 28, 2020
Estimated Study Completion Date :	August 1, 2021

To Top